Tus kws kho mob
QP112R1-20 Changes to Electronic Funds Transfer Processes
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 22, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1241 - 1250 ntawm 4204
Tus kws kho mob
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 22, 2023
Tus kws kho mob
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 22, 2023
Tus kws kho mob
bc-mhcp-pharmprogpolicynotifctn-final-eff-3.1.23.pdf
Tus kws kho mob
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2023
Tus kws kho mob
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2023
Tus kws kho mob
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2023
Tus kws kho mob
QP9-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2023